Replies to post #80786 on NorthWest Biotherapeutics Inc (NWBO)

[maverick_1]

Unlike most I go with my senses over a period of time to validate the authenticity of a poster.

Other than that you are a fleet afoot: it was just a strong hunch of mine versus not having time to even begin to delve into the prospectus or even to uncover what you expressed.

Simply put for that buyer:
1. His windfall and deployment options.
2. VB-111 is KEY for reasons you probably are aware of as Roth was IBK (being intentionally vague here)
3. Fondness for market MISPERCEPTIONS and ability to buy in size especially a sub $1 issue

ON CEO Linda Powers side: HUGE positives
1. ADD lots of needed institutional credibility to attract other Big Fish
2. Manipulators will hasten and retreat versus that of retail!
2. LESSER float/servicing irritations (freeing up LG's load)to deal with compared with Retail @ Roth

ON Roth side:
1. Profits stream bigger and longer servicing retail vs institutional

Off the veritable top, that will have to do for now: look for a PM Fri Happy Hr.